Literature DB >> 29702490

Rationale to reduce calcium intake in adult patients with chronic kidney disease.

Sharon M Moe1,2.   

Abstract

PURPOSE OF REVIEW: Calcium is an essential ion for the maintenance of normal bone health and physiologic functions. The extracellular and intracellular levels of calcium are maintained through hormonal regulation called homeostasis. Balance, the net intake minus excretion of calcium, is maintained by hormonal regulation of intestinal absorption and fecal/urinary excretion. Homeostasis and balance are disconnected in patients with chronic kidney disease (CKD). The purpose of this review is to understand how calcium homeostasis and balance are impaired in CKD. RECENT
FINDINGS: Two formal calcium balance studies have found that an oral intake of 800-1000 mg of calcium in adults with CKD leads to neutral calcium balance, whereas amounts greater than that lead to positive calcium balance. In patients with CKD, the main determinant of positive calcium balance is the intake and the lack of urinary calcium excretion.
SUMMARY: Calcium balance is different in patients with advanced CKD compared with patients without CKD. Thus, the oral intake of calcium in the form of diet and binders should not exceed 800-1000 mg/day to achieve neutral calcium balance in adult patients with CKD stages 3b/4.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29702490      PMCID: PMC6454891          DOI: 10.1097/MNH.0000000000000416

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  40 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Calcium balance during human growth: evidence for threshold behavior.

Authors:  V Matkovic; R P Heaney
Journal:  Am J Clin Nutr       Date:  1992-05       Impact factor: 7.045

3.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Authors:  Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

4.  Albumin-corrected calcium and ionized calcium in stable haemodialysis patients.

Authors:  C M Clase; G L Norman; M L Beecroft; D N Churchill
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

5.  Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor.

Authors:  Alfredo Scillitani; Vito Guarnieri; Simona De Geronimo; Lucia Anna Muscarella; Claudia Battista; Leonardo D'Agruma; Francesco Bertoldo; Cinzia Florio; Salvatore Minisola; Geoffrey N Hendy; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

Review 6.  Recent developments in intestinal calcium absorption.

Authors:  Felix Bronner
Journal:  Nutr Rev       Date:  2009-02       Impact factor: 7.110

7.  The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.

Authors:  D Russo; I Miranda; C Ruocco; Y Battaglia; E Buonanno; S Manzi; L Russo; A Scafarto; V E Andreucci
Journal:  Kidney Int       Date:  2007-09-05       Impact factor: 10.612

8.  A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Authors:  Wajeh Qunibi; Moustafa Moustafa; Larry R Muenz; David Y He; Paul D Kessler; Jose A Diaz-Buxo; Mathew Budoff
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

9.  Cinacalcet reduces the set point of the PTH-calcium curve.

Authors:  Casimiro Valle; Mariano Rodriguez; Rafael Santamaría; Yolanda Almaden; Maria E Rodriguez; Sagrario Cañadillas; Alejandro Martin-Malo; Pedro Aljama
Journal:  J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 10.121

10.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  5 in total

Review 1.  Nutritional Supplements and Skeletal Health.

Authors:  Laila S Tabatabai; Deborah E Sellmeyer
Journal:  Curr Osteoporos Rep       Date:  2021-01-09       Impact factor: 5.096

Review 2.  Recent Advances in the Role of Diet in Bone and Mineral Disorders in Chronic Kidney Disease.

Authors:  Orlando M Gutiérrez
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

Review 3.  Inflammation: a putative link between phosphate metabolism and cardiovascular disease.

Authors:  Jakob Voelkl; Daniela Egli-Spichtig; Ioana Alesutan; Carsten A Wagner
Journal:  Clin Sci (Lond)       Date:  2021-01-15       Impact factor: 6.124

Review 4.  A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.

Authors:  Geeta Hampson; Grahame J Elder; Martine Cohen-Solal; Bo Abrahamsen
Journal:  Endocrine       Date:  2021-05-11       Impact factor: 3.633

Review 5.  Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression.

Authors:  Sandro Mazzaferro; Natalia de Martini; Jorge Cannata-Andía; Mario Cozzolino; Piergiorgio Messa; Silverio Rotondi; Lida Tartaglione; Marzia Pasquali
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.